APP and Alzheimer disease: In transgenic AD mouse model of APP/PS1/Nlrp3−/−, NLRP3 deficiency reduces amyloid-β deposition and cognitive dysfunction by microglial mediated amyloid-β phagocytosis (Heneka et al., 2013).